These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Albendazole: a new therapeutic regimen in cutaneous larva migrans. Rizzitelli G; Scarabelli G; Veraldi S Int J Dermatol; 1997 Sep; 36(9):700-3. PubMed ID: 9352416 [TBL] [Abstract][Full Text] [Related]
8. Two imported cases of cutaneous larva migrans. Park JW; Kwon SJ; Ryu JS; Hong EK; Lee JU; Yu HJ; Ahn MH; Min DY Korean J Parasitol; 2001 Mar; 39(1):77-81. PubMed ID: 11301593 [TBL] [Abstract][Full Text] [Related]
9. Treatment of larva migrans syndrome with long-term administration of albendazole. Hombu A; Yoshida A; Kikuchi T; Nagayasu E; Kuroki M; Maruyama H J Microbiol Immunol Infect; 2019 Feb; 52(1):100-105. PubMed ID: 28754237 [TBL] [Abstract][Full Text] [Related]
10. Cutaneous larva migrans in infants in the Adelaide Hills. Black MD; Grove DI; Butcher AR; Warren LJ Australas J Dermatol; 2010 Nov; 51(4):281-4. PubMed ID: 21198527 [TBL] [Abstract][Full Text] [Related]
11. Cutaneous larva migrans contracted in England: a reminder. Roest MA; Ratnavel R Clin Exp Dermatol; 2001 Jul; 26(5):389-90. PubMed ID: 11488822 [TBL] [Abstract][Full Text] [Related]
12. Cutaneous Larva Migrans with Löeffler's Syndrome. Gao YL; Liu ZH Am J Trop Med Hyg; 2019 Mar; 100(3):487-488. PubMed ID: 30843502 [No Abstract] [Full Text] [Related]